eSUN
A global leader in bio-materials and 3D printing, specializing in the research, production, and sale of high-quality filaments, resins, and biodegradable polymers like PLA and PCL.
- CEO / Founder
- Yang Yihu (Kevin Yang)
- Team Size
- 500+
- Stage
- Publicly traded (NEEQ: 836514); recognized as a 'Little Giant' enterprise and a 'National High-Tech Enterprise' in China, currently in a high-growth phase with over 40% year-over-year revenue growth reported in 2024.
- Total Funding
- $15.0M
- Latest Round
- Public Listing (NEEQ: 836514)
- Key Investors
- ["Shenzhen Capital Group (SCGC)","Dongxing Securities"]
Technology & Products
Key Products
["FDM 3D Filaments (PLA+, ABS, PETG, TPU, Carbon Fiber, PA, PC, PVA)","Photopolymer Resins (Bio-based, Standard, Water-Washable W200, Dental, Castable)","iSUN3D Customized Footwear System (3D printed insoles and orthopedic solutions)","Bio-based Materials (PLA coated paper, biodegradable microspheres, PCL for medical/industrial use)","Implant-grade PLLA 3D printing filaments and medical raw materials"]
Technological Advantage
Maintains a first-mover advantage as the primary drafting unit for China's national standards for PLA 3D printing consumables; holds the world's first patent for bio-based photopolymer resins.
Market & Competition
Target Customers
Consumer-grade 3D printing enthusiasts (makers), educational institutions, industrial manufacturing firms, dental labs, and medical rehabilitation centers.
Industry Verticals
["Additive Manufacturing","Healthcare & Medical (Orthotics, Dentistry, Implants)","Education & Research","Industrial Design & Prototyping","Agriculture (Biodegradable products)","Consumer Electronics & Wearables"]
Competitors
["Polymaker","Hatchbox","Sunlu","Formlabs"]